fbpx

Cian Healthcare Limited IPO – Review, Allotment, Subscription, GMP & DRHP

Let’s have a detailed review of the company and analytics of the Cian Healthcare Limited IPO release date, IPO offer price, subscription, Cian Healthcare IPO allotment, grey market price and other details like the company’s background, its financial positions, its promoters and other related things.

Cian Healthcare Limited is engaged in the business of manufacturing wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products. This Company has a full-fledged F & D and regulatory department. 


Cian Healthcare IPO Review & Ratings

IPO Ratings & Review
CriteriaRatings
Industry Sentiments7.5/10
Industry Ranking7.8/10
Company Background7.7/10
Company Reputation7.5/10
Competitive Edge7.7/10
Financial Statements7.8/10
Popularity Index7.4/10
Promoters Reputation7.7/10
Retail Appetite7.9/10
Top Brokers Review7.6/10
Overall Ratings7.6/10
Star Ratings★★★★☆

Summary of Cian Healthcare Limited IPO

Cian Healthcare Limited IPOCian Healthcare Limited is engaged in the business of manufacturing wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products.

It develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management.

From FY 2015-16 to FY 2017-2018, as per the Restated Financial Statements,

  • The Company’s total revenue as restated in Financial Year 2018, 2017 and 2016 was Rs. 5959.34 lakhs, Rs. 5185.36 lakhs and Rs. 4715. 62 lakhs, respectively.
  • The net worth as on  September 30,  2018 was Rs. 2226.84 lakhs and Rs. 1716.81 lakhs as of Mar 31, 2018 as per the Restated Consolidated Financial Statements.
  • The net asset value per Equity Share as of Mar 30, 2018, is Rs. 122.63.
  • Company’s profit/loss after tax as restated in Financial Year 2018, 2017 and 2016 was Rs. 387.35 lakhs, Rs. 231.28 lakhs and Rs. 154.71 lakhs, respectively. 

The Promoters of this company are Suraj Zanwar and Kavita Zanwar.  The lead manager to the issue is Fedex Securities Private Limited and the Registrar to this issue is Bigshare Services Private Limited .



Cian Healthcare IPO Date

The opening and the closing date of Cian Healthcare IPO is May 2, 2019 – May 15, 2019,


Cian Healthcare IPO Subscription

Day / DateNIIRIITotal Subscription
1st Day – May 20.05x0.03x0.04x
2nd Day – May 30.10x0.08x0.09x
3rd Day – May 60.27x0.15x0.21x
4th Day – May 70.40x0.17x0.29x
5th Day – May 80.46x0.21x0.33x
6th Day – May 90.59x0.17x0.38x
7th Day – May 100.59x0.17x0.38x
8th Day – May 130.60x0.17x0.39x
9th Day – May 140.73x0.22x0.47x
10th Day – May 151.91x0.59x1.25x
Shares Offered or Net Issue2,950,0002,950,0005,900,000

The shares subscribed by the public will be updated here.


Cian Healthcare IPO Allotment Status

Here, you can find the Allotment Status of this IPO.

Basis of Allotment Finalization14-May-19
Refunds Initiation15-May-19
Credit of Shares to Demat Account16-May-19
Share Listing Date17-May-19

Cian Healthcare IPO Price Band

The face value of each share is Rs 10, but the price band of the IPO is Rs 61 – Rs 65. 


Cian Healthcare IPO Equity Share Offering

Initial public offering of up to 62,16,000 Shares of face value of Rs. 10 each fully paid-up for cash at price of Rs 61 – Rs 65 per Equity Share aggregating to Rs. 400 Lakhs.


Cian Healthcare Limited – Company Overview

The company, Cian Healthcare Limited was originally incorporated as “Cian Healthcare Private Limited” as a private limited Company under the provisions of Companies Act, 1956 vide Certificate of Incorporation dated January 17, 2003.

Cian Healthcare manufacture is a WHO-GMP & ISO -9001:2015 certified transnational manufacturing Company with wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products. Company has a full-fledged F & D and regulatory department. The company complies with the standard manufacturing practices as laid down by the World Health Organization and is also certified by the Food and Drug Control Administration. 

It develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals, alongwith 10 sales division focused on developing and growing the engagements in specialist and super specialist division.

This company works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies.

Competitive Strengths of Cian Healthcare Limited:

  • Established Manufacturing Facility
  • Strong Formulations and Development Capabilities
  • Diversified Business Portfolio
  • Experienced core Management Team
  • Strong Financial performance
  • Product Range

Business strategies of Cian Healthcare Limited:

  • Broaden and Deepen the presence at Global level
  • Investment in R&D driving sustainable growth
  • Expansion Plans

Cian Healthcare Limited – Financial Statements

A quick look into the past financial performance of the company to understand its performance of business and evaluate the growth prospectus:

Financial Summary:

On the basis of Standalone statement:-

Amount (in INR & lakhs)
30-Sept-1831-Mar-1831-Mar-1731-Mar-16
Total Assets8,112.217,762.476,127.825,681.81
Total Revenue3,301.455,959.345,185.364,715.62
Total Expense2,780.565,446.334,877.474,499.60
Profit After Tax520.89513.01307.89216.02

Earnings per Equity Share (in millions)

30-Sept-1831-Mar-1831-Mar-1731-Mar-16
Basic28.4427.6716.5215.45
Diluted
7.9327.6716.5215.45

From the above statements, one could find that the Cian Healthcare Limited may perform well.


Cian Healthcare IPO – Promoters

The Promoters of this company are:

  • Suraj Zanwar
  • Kavita Zanwar

List of Related Parties (Key Managerial Personnel)

  • Suraj Zanwar
  • Riyaz Khan
  • Chandra Prakash Singh –  Chief Finance Officer
  • Usha Jaswani –  Company Secretary & Compliance Officer

Interest in promotion of the Company

Company is currently promoted by the Promoters in order to carry on its present business. Promoters are interested in the Company to the extent of their shareholding and directorship of the Individual Promoter in the Company and the dividend declared, if any, by the Company. The Promoters are interested in the transactions entered into the Company and the Promoter Group.

Property Interest

The promoters along with the promoter group will continue to hold collectively some percentage of the equity share capital of the company. As a result of the same, they will be able to exercise significant influence over the control of the outcome of the matter that requires approval of the majority shareholders vote.

Interest in Intellectual Rights of the Company

Promoters has not shown any interest in acquiring the intellectual rights of the company.


Cian Healthcare IPO Offer Details or Issue Details

Particulars No. Of Equity Shares
 Equity Shares Offered Up to 62,16,000 Shares of face value of Rs. 10 
 Of which:
 Reserved for Market Makers Up to [●] Equity Shares of face value of Rs. 10 each 
 Net Issue to the Public Up to [●] Shares of face value of Rs. 10 each 
 Of which:
 Retail Investors Portion [●] Shares of face value of Rs. 10 each fully paid-up for cash at price of Rs. [●] per Equity Share aggregating to Rs. [●] Lakhs i.e. 50% of the Net Issue shall be available for allocation Retail Individual Investors
 Non-Retail Investors Portion 50% of the Net Issue shall be available for allocation for Investors other than Retail Individual Investors
 Equity Shares outstanding prior to the Issue[●] Equity Shares
 Shares outstanding after the IssueUpto [●] Equity Shares of face value of Rs. 10 each

Cian Healthcare IPO Issue Object

These are the IPO Issue Objects of the company

  • Funding the Working Capital requirements of the Company:
  • Margin Money for Setting up of manufacturing facility i.e. Unit 2 situated at Roorkee,
    Uttarakhand, India.
  •  Upgradation of existing plant i.e. Unit 1 situated at Roorkee, Uttarakhand, India
  • Enhancement of our Company’s brand through advertising and other brand-building activities
  • Acquisitions and other strategic initiatives

Cian Healthcare IPO – Basis of the Offer Price

The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

The Qualitative factors are:

  • Market leader in wires and cables in India
  • Diverse suite of electrical products with varied applications across a diverse customer base
  • Strong distribution network
  • Manufacturing facilities with high degree of backward integration
  • Strong brand in the electrical industry
  • Experienced and committed management team

The relevant quantitative factors are:

Basic & Diluted EPS(Pre Bonus)Basic & Diluted EPS(Post Bonus)

 

RONW in %NAV (Rs.)(Pre Bonus)NAV (Rs.) (Post Bonus)
31-Mar-1615.450.9414.09
31-Mar-1716.521.3817.40
31-Mar-1827.672.3122.56
122.6310.22
  • Price to Earnings (P/E) ratio in relation to Price Band of Rs. [●] and [●] per Equity Share of Rs. 10 each fully paid up
ParticularsP/E ratio
Highest62.07
Average53.77
Lowest11.27
  • Competitive Peers:
Sr. No. ParticularsFace Value  (in Rs.)Diluted EPS (In Rs.)P/E RatioRONW (%) NAV (In Rs.)
1Cian Healthcare
Limited
1026.2222.5610.22
2Deccan Healthcare
Limited
1010.576.6227.02
3Zota Healthcare
Limited
108.1962.0710.423.98
4Sakar Healthcare
Limited  
105.1521.968.153.83
5Jenburkt
Pharmaceuticals
Limited
1018.2112.2728.10133.48

Cian Healthcare IPO Lead Managers

Lead Managers
FEDEX SECURITIES PRIVATE LIMITED
305, Enterprise Centre, Nehru Road, Vile Parle
(East), Mumbai 400099, Maharashtra, India.
Tel No.: +9181049 85249
Fax No.: 022 2618 6966
E-mail:
Website: www.fedsec.in
Contact Person: Rinkesh Saraiya
SEBI Registration Number: INM000010163
Investor Grievance E-mail:

Cian Healthcare IPO Registrar to offer

Registrar to the Offer
BIGSHARE SERVICES PRIVATE LIMITED
1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana
Road, Marol, Andheri East, Mumbai-400 059, India.
Tel No.: +91 22 62638200
Fax No.: +91 22 62638299
E-mail:
Website: www.bigshareonline.com
Contact Person: Babu Raphael
SEBI Registration No.: INR000001385
Investor Grievance E-mail:

Other Details:

  • Statutory Auditor – M/s Agarwal Dhand Motwani & Co, Chartered Accountants
  • Peer Review Auditor – M/s A. Biyani & Co., Chartered Accountants
  • Bankers to the Company – Small Industries Development Bank of India, Industrial Development Bank of India, Dena Bank, Corporation Bank, Vijaya Bank.

Cian Healthcare IPO Review by Top 10 Stock Brokers

Top Stock Brokers ReviewCompany ReputationCompetitive EdgeFinancial StatementPopularity IndexPromoters Reputation
Angel Broking7.5/107.4/108.5/108.1/107.1/10
Sharekhan7.2/107.1/108.6/108.1/107.2/10
Kotak Securities7.3/107.5/108.4/108.1/107.3/10
ICICI Direct7.3/107.3/108.7/108.1/107.1/10
IIFL7.5/107.2/108.8/108.0/107.1/10
Edelweiss7.5/107.4/108.4/108.3/107.2/10
Zerodha7.4/107.1/108.5/108.1/107.0/10
5Paisa7.1/107.1/108.4/108.1/107.1/10
Karvy7.4/107.3/108.2/108.1/107.1/10
Motilal Oswal7.1/107.1/108.6/108.3/107.2/10

Cian Healthcare IPO Grey Market Premium

The Cian Healthcare IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is X. 


Subscribe to Cian Healthcare IPO

Fill the Details Below
  1. Subscribe to IPOOpen Demat AccountBecome Sub Broker


Cian Healthcare IPO News

News 1 – IPO ISSUE OPENS SOON [Download Prospectus]


Market Guide

What is IPO?
IPO Investment
IPO Valuation
Upcoming IPOs

Featured Topics

Top 10 Discount Brokers
Authorised Person
Top 10 Full Service Brokers in India
Best Demat Account in India
Stock Broker Comparison
Top 10 Intraday Trading Brokers
Stock Market Franchise
Top 10 Broking Franchise
Sub Broker Franchise

Leave a Reply

Your email address will not be published. Required fields are marked *

Get 100% IPO Allotment Guarantee! Subscribe to IPO
×

Share your details & Become Sub Broker Now!

  1. Become Sub BrokerOpen Demat Account

Offer valid for limited time.

×

Share your details & Open Demat A/C Now!

  1. Open Demat AccountBecome Sub Broker

Offer valid for limited time.

×

Share your details & Get IPO Allotment Now!

  1. Invest in IPOOpen Demat Account

Offer valid for limited time.

×

Share your details & Invest in PMS Now!

  1. Invest in PMSOpen Demat Account

Offer valid for limited time.